Risk	B:C0035648
Factors	I:C0035648
,	O
Clinical	O
Features	O
,	O
and	O
Treatment	O
Outcomes	O
of	O
Recurrent	O
Mooren	O
Ulcers	I:C0155072
in	O
China	O

Risk	O
Factors	I:C0035648
,	O
Clinical	O
Features	O
,	O
and	O
Treatment	O
Outcomes	O
of	O
Recurrent	O
Mooren	B:C0155072
Ulcers	I:C0155072
in	O
China	O

Risk	O
Factors	I:C0035648
,	O
Clinical	O
Features	O
,	O
and	O
Treatment	O
Outcomes	O
of	O
Recurrent	O
Mooren	O
Ulcers	I:C0155072
in	O
China	B:C0008115

To	O
investigate	O
risk	B:C0035648
factors	I:C0035648
,	O
clinical	O
features	O
,	O
and	O
treatment	O
outcomes	O
of	O
recurrent	O
Mooren	O
ulcers	I:C0155072
in	O
China	O
.	O

To	O
investigate	O
risk	O
factors	I:C0035648
,	O
clinical	O
features	O
,	O
and	O
treatment	O
outcomes	O
of	O
recurrent	O
Mooren	B:C0155072
ulcers	I:C0155072
in	O
China	O
.	O

To	O
investigate	O
risk	O
factors	I:C0035648
,	O
clinical	O
features	O
,	O
and	O
treatment	O
outcomes	O
of	O
recurrent	O
Mooren	O
ulcers	I:C0155072
in	O
China	B:C0008115
.	O

Medical	B:C0025102
records	I:C0025102
of	O
139	O
patients	O
(	O
173	O
eyes	O
)	O
with	O
Mooren	O
ulcers	I:C0155072
,	O
including	O
37	O
patients	O
(	O
38	O
eyes	O
)	O
with	O
recurrence	O
,	O
were	O
retrospectively	O
reviewed	O
.	O

Medical	O
records	I:C0025102
of	O
139	O
patients	O
(	O
173	O
eyes	B:C0015392
)	O
with	O
Mooren	O
ulcers	I:C0155072
,	O
including	O
37	O
patients	O
(	O
38	O
eyes	O
)	O
with	O
recurrence	O
,	O
were	O
retrospectively	O
reviewed	O
.	O

Medical	O
records	I:C0025102
of	O
139	O
patients	O
(	O
173	O
eyes	O
)	O
with	O
Mooren	B:C0155072
ulcers	I:C0155072
,	O
including	O
37	O
patients	O
(	O
38	O
eyes	O
)	O
with	O
recurrence	O
,	O
were	O
retrospectively	O
reviewed	O
.	O

Medical	O
records	I:C0025102
of	O
139	O
patients	O
(	O
173	O
eyes	O
)	O
with	O
Mooren	O
ulcers	I:C0155072
,	O
including	O
37	O
patients	O
(	O
38	O
eyes	B:C0015392
)	O
with	O
recurrence	O
,	O
were	O
retrospectively	O
reviewed	O
.	O

Clinical	O
features	O
and	O
treatment	O
outcomes	O
were	O
evaluated	B:C0220825
.	O

The	O
risk	B:C0035648
factors	I:C0035648
for	O
ulcer	O
recurrence	O
were	O
analyzed	O
with	O
logistic	O
regression	I:C0206031
;	O
the	O
cumulative	O
risk	O
of	O
recurrence	O
was	O
assessed	O
with	O
Kaplan	O
-	O
Meier	O
analysis	O
.	O

The	O
risk	O
factors	I:C0035648
for	O
ulcer	B:C0041582
recurrence	O
were	O
analyzed	O
with	O
logistic	O
regression	I:C0206031
;	O
the	O
cumulative	O
risk	O
of	O
recurrence	O
was	O
assessed	O
with	O
Kaplan	O
-	O
Meier	O
analysis	O
.	O

The	O
risk	O
factors	I:C0035648
for	O
ulcer	O
recurrence	O
were	O
analyzed	B:C0936012
with	O
logistic	O
regression	I:C0206031
;	O
the	O
cumulative	O
risk	O
of	O
recurrence	O
was	O
assessed	O
with	O
Kaplan	O
-	O
Meier	O
analysis	O
.	O

The	O
risk	O
factors	I:C0035648
for	O
ulcer	O
recurrence	O
were	O
analyzed	O
with	O
logistic	B:C0206031
regression	I:C0206031
;	O
the	O
cumulative	O
risk	O
of	O
recurrence	O
was	O
assessed	O
with	O
Kaplan	O
-	O
Meier	O
analysis	O
.	O

The	O
ratio	O
of	O
males	O
to	O
females	O
with	O
Mooren	B:C0155072
ulcers	I:C0155072
was	O
1.62:1	O
.	O

Forty	O
-	O
one	O
patients	O
had	O
bilateral	B:C1511113
disease	I:C1511113
(	O
7	O
eyes	O
removed	O
before	O
their	O
visit	O
to	O
our	O
hospital	O
were	O
excluded	O
)	O
and	O
98	O
patients	O
had	O
unilateral	O
disease	O
,	O
with	O
recurrence	O
in	O
10	O
and	O
27	O
patients	O
,	O
respectively	O
.	O

Forty	O
-	O
one	O
patients	O
had	O
bilateral	O
disease	I:C1511113
(	O
7	O
eyes	B:C0015392
removed	O
before	O
their	O
visit	O
to	O
our	O
hospital	O
were	O
excluded	O
)	O
and	O
98	O
patients	O
had	O
unilateral	O
disease	O
,	O
with	O
recurrence	O
in	O
10	O
and	O
27	O
patients	O
,	O
respectively	O
.	O

Forty	O
-	O
one	O
patients	O
had	O
bilateral	O
disease	I:C1511113
(	O
7	O
eyes	O
removed	O
before	O
their	O
visit	O
to	O
our	O
hospital	B:C0019994
were	O
excluded	O
)	O
and	O
98	O
patients	O
had	O
unilateral	O
disease	O
,	O
with	O
recurrence	O
in	O
10	O
and	O
27	O
patients	O
,	O
respectively	O
.	O

Thirty	O
eyes	B:C0015392
had	O
recurrence	O
around	O
the	O
primary	O
lesion	I:C1402294
;	O
27	O
eyes	O
had	O
recurrence	O
within	O
12	O
months	O
after	O
treatment	O
.	O

Thirty	O
eyes	O
had	O
recurrence	O
around	O
the	O
primary	B:C1402294
lesion	I:C1402294
;	O
27	O
eyes	O
had	O
recurrence	O
within	O
12	O
months	O
after	O
treatment	O
.	O

Thirty	O
eyes	O
had	O
recurrence	O
around	O
the	O
primary	O
lesion	I:C1402294
;	O
27	O
eyes	B:C0015392
had	O
recurrence	O
within	O
12	O
months	O
after	O
treatment	O
.	O

Thirty	O
eyes	O
had	O
recurrence	O
around	O
the	O
primary	O
lesion	I:C1402294
;	O
27	O
eyes	O
had	O
recurrence	O
within	O
12	O
months	O
after	O
treatment	B:C0087111
.	O

Of	O
all	O
eyes	B:C0015392
,	O
97.7	O
%	O
were	O
saved	O
and	O
81.5	O
%	O
retained	O
vision	O
better	O
than	O
0.05	O
.	O

Of	O
all	O
eyes	O
,	O
97.7	O
%	O
were	O
saved	O
and	O
81.5	O
%	O
retained	O
vision	B:C0042789
better	O
than	O
0.05	O
.	O

Male	O
sex	O
(	O
P	O
=	O
0.043	O
)	O
and	O
surgical	B:C0543467
treatment	I:C0543467
(	O
P	O
=	O
0.035	O
)	O
were	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
recurrence	O
.	O

This	O
study	B:C2603343
provided	O
the	O
clinical	O
characteristics	O
and	O
treatment	O
outcomes	O
of	O
patients	O
with	O
recurrent	O
Mooren	O
ulcers	I:C0155072
in	O
China	O
.	O

This	O
study	O
provided	O
the	O
clinical	O
characteristics	O
and	O
treatment	O
outcomes	O
of	O
patients	O
with	O
recurrent	O
Mooren	B:C0155072
ulcers	I:C0155072
in	O
China	O
.	O

This	O
study	O
provided	O
the	O
clinical	O
characteristics	O
and	O
treatment	O
outcomes	O
of	O
patients	O
with	O
recurrent	O
Mooren	O
ulcers	I:C0155072
in	O
China	B:C0008115
.	O

The	O
cumulative	O
risk	O
of	O
first	O
recurrence	O
at	O
4	O
years	O
after	O
treatment	B:C0087111
was	O
28.6	O
%	O
.	O

Male	O
patients	O
and	O
patients	O
with	O
severe	O
ulcers	B:C0041582
that	O
required	O
surgery	O
had	O
an	O
increased	O
risk	O
of	O
recurrence	O
.	O

Male	O
patients	O
and	O
patients	O
with	O
severe	O
ulcers	O
that	O
required	O
surgery	B:C0543467
had	O
an	O
increased	O
risk	O
of	O
recurrence	O
.	O

